CELL REP 润色咨询

Cell Reports

出版年份：暂无数据 年文章数：10575 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：2.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2129298, encodeId=b2fe21292989b, content=好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Sat Apr 29 21:47:11 CST 2023, time=2023-04-29, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124144, encodeId=31c62124144b4, content=偏重的研究方向：肿瘤<br>经验分享：请问cell report 需要提供所有的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb538107486, createdName=ms5000001244389384, createdTime=Thu Apr 06 16:50:15 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124142, encodeId=6be1212414218, content=偏重的研究方向：肿瘤<br>经验分享：请问目前cell report投稿需要提交所有的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb538107486, createdName=ms5000001244389384, createdTime=Thu Apr 06 16:43:11 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1063947, encodeId=90b2106394e9f, content=偏重的研究方向：医学;综合;生物学<br>经验分享：请问和sicnece signaling比哪个难度大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bcd2757433, createdName=826449277, createdTime=Tue Oct 26 06:34:58 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118532, encodeId=4857211853246, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：好杂志，推荐，刚刚中了，作为一个研究生，是不是还不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de436514664, createdName=ms5000001366657176, createdTime=Thu Mar 09 19:15:29 CST 2023, time=2023-03-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223966, encodeId=142e12239666a, content=请教各位前辈，现在这个杂志发表前要求提供PCR原始数据嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5e4748995, createdName=SCI 99, createdTime=Thu Jun 02 01:00:07 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545925, encodeId=158454592530, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：个人感觉目前难度不是很大，相比eLife, PNAS有点差距，不过文章整体质量还是非常好。我的个人经历是投稿到Oncogene结果人家都不审稿，再投到了Cell Rep,小修后接受了，所以投稿的时候还要看是否遇到了欣赏你工作的编辑及审稿人吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08d965864, createdName=xianjuema, createdTime=Sat Aug 26 01:56:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099255, encodeId=ead6209925505, content=一年中无理由的无评语的连续被拒了8次，也不分析为什么被拒，要求重新修改，一直拒绝不可以，说是已经服务了，这算是人性化的服务吗，白白浪费了三万多钱，也浪费时间，一直说服务到位了，中间也没有沟通也不给意见，大家合作时慎重考虑，因为我也没想到会一直被拒，提意见也不接受，我怕大家会出现我的情况，好好参考下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=929c5718991, createdName=ms4000002056955167, createdTime=Tue Nov 08 20:55:43 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232664, encodeId=e8501232664c5, content=求问各位大大送审后修回机率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/28/80e2808f5601a0210ea7aa90667fc272.jpg, createdBy=fe532106727, createdName=yyyanz, createdTime=Fri Jul 15 19:17:20 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564653, encodeId=ccbd56465366, content=是么？<span class="quote">控球后卫-姚明 2018-05-29 发表::<br>我刚发一篇.说实话.这个期刊要求真心不高</span><span class="quote">加州理工的工人 2018-05-29 05:21:00 发表:<br>我刚发一篇.说实话.这个期刊要求真心不高</span>, beContent=控球后卫-姚明 2018-05-29 发表:: 我刚发一篇.说实话.这个期刊要求真心不高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=743, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd1b2506977, createdName=124af5d5m75暂无昵称, createdTime=Wed Dec 19 00:00:00 CST 2018, time=2018-12-19, status=1, ipAttribution=)]
    2023-04-29 ms2000000147841561 来自河北省

    好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2129298, encodeId=b2fe21292989b, content=好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Sat Apr 29 21:47:11 CST 2023, time=2023-04-29, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124144, encodeId=31c62124144b4, content=偏重的研究方向：肿瘤<br>经验分享：请问cell report 需要提供所有的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb538107486, createdName=ms5000001244389384, createdTime=Thu Apr 06 16:50:15 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124142, encodeId=6be1212414218, content=偏重的研究方向：肿瘤<br>经验分享：请问目前cell report投稿需要提交所有的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb538107486, createdName=ms5000001244389384, createdTime=Thu Apr 06 16:43:11 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1063947, encodeId=90b2106394e9f, content=偏重的研究方向：医学;综合;生物学<br>经验分享：请问和sicnece signaling比哪个难度大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bcd2757433, createdName=826449277, createdTime=Tue Oct 26 06:34:58 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118532, encodeId=4857211853246, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：好杂志，推荐，刚刚中了，作为一个研究生，是不是还不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de436514664, createdName=ms5000001366657176, createdTime=Thu Mar 09 19:15:29 CST 2023, time=2023-03-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223966, encodeId=142e12239666a, content=请教各位前辈，现在这个杂志发表前要求提供PCR原始数据嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5e4748995, createdName=SCI 99, createdTime=Thu Jun 02 01:00:07 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545925, encodeId=158454592530, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：个人感觉目前难度不是很大，相比eLife, PNAS有点差距，不过文章整体质量还是非常好。我的个人经历是投稿到Oncogene结果人家都不审稿，再投到了Cell Rep,小修后接受了，所以投稿的时候还要看是否遇到了欣赏你工作的编辑及审稿人吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08d965864, createdName=xianjuema, createdTime=Sat Aug 26 01:56:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099255, encodeId=ead6209925505, content=一年中无理由的无评语的连续被拒了8次，也不分析为什么被拒，要求重新修改，一直拒绝不可以，说是已经服务了，这算是人性化的服务吗，白白浪费了三万多钱，也浪费时间，一直说服务到位了，中间也没有沟通也不给意见，大家合作时慎重考虑，因为我也没想到会一直被拒，提意见也不接受，我怕大家会出现我的情况，好好参考下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=929c5718991, createdName=ms4000002056955167, createdTime=Tue Nov 08 20:55:43 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232664, encodeId=e8501232664c5, content=求问各位大大送审后修回机率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/28/80e2808f5601a0210ea7aa90667fc272.jpg, createdBy=fe532106727, createdName=yyyanz, createdTime=Fri Jul 15 19:17:20 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564653, encodeId=ccbd56465366, content=是么？<span class="quote">控球后卫-姚明 2018-05-29 发表::<br>我刚发一篇.说实话.这个期刊要求真心不高</span><span class="quote">加州理工的工人 2018-05-29 05:21:00 发表:<br>我刚发一篇.说实话.这个期刊要求真心不高</span>, beContent=控球后卫-姚明 2018-05-29 发表:: 我刚发一篇.说实话.这个期刊要求真心不高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=743, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd1b2506977, createdName=124af5d5m75暂无昵称, createdTime=Wed Dec 19 00:00:00 CST 2018, time=2018-12-19, status=1, ipAttribution=)]
    2023-04-06 ms5000001244389384 来自上海

    偏重的研究方向：肿瘤
    经验分享：请问cell report 需要提供所有的原始数据吗

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2129298, encodeId=b2fe21292989b, content=好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Sat Apr 29 21:47:11 CST 2023, time=2023-04-29, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124144, encodeId=31c62124144b4, content=偏重的研究方向：肿瘤<br>经验分享：请问cell report 需要提供所有的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb538107486, createdName=ms5000001244389384, createdTime=Thu Apr 06 16:50:15 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124142, encodeId=6be1212414218, content=偏重的研究方向：肿瘤<br>经验分享：请问目前cell report投稿需要提交所有的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb538107486, createdName=ms5000001244389384, createdTime=Thu Apr 06 16:43:11 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1063947, encodeId=90b2106394e9f, content=偏重的研究方向：医学;综合;生物学<br>经验分享：请问和sicnece signaling比哪个难度大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bcd2757433, createdName=826449277, createdTime=Tue Oct 26 06:34:58 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118532, encodeId=4857211853246, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：好杂志，推荐，刚刚中了，作为一个研究生，是不是还不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de436514664, createdName=ms5000001366657176, createdTime=Thu Mar 09 19:15:29 CST 2023, time=2023-03-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223966, encodeId=142e12239666a, content=请教各位前辈，现在这个杂志发表前要求提供PCR原始数据嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5e4748995, createdName=SCI 99, createdTime=Thu Jun 02 01:00:07 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545925, encodeId=158454592530, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：个人感觉目前难度不是很大，相比eLife, PNAS有点差距，不过文章整体质量还是非常好。我的个人经历是投稿到Oncogene结果人家都不审稿，再投到了Cell Rep,小修后接受了，所以投稿的时候还要看是否遇到了欣赏你工作的编辑及审稿人吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08d965864, createdName=xianjuema, createdTime=Sat Aug 26 01:56:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099255, encodeId=ead6209925505, content=一年中无理由的无评语的连续被拒了8次，也不分析为什么被拒，要求重新修改，一直拒绝不可以，说是已经服务了，这算是人性化的服务吗，白白浪费了三万多钱，也浪费时间，一直说服务到位了，中间也没有沟通也不给意见，大家合作时慎重考虑，因为我也没想到会一直被拒，提意见也不接受，我怕大家会出现我的情况，好好参考下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=929c5718991, createdName=ms4000002056955167, createdTime=Tue Nov 08 20:55:43 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232664, encodeId=e8501232664c5, content=求问各位大大送审后修回机率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/28/80e2808f5601a0210ea7aa90667fc272.jpg, createdBy=fe532106727, createdName=yyyanz, createdTime=Fri Jul 15 19:17:20 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564653, encodeId=ccbd56465366, content=是么？<span class="quote">控球后卫-姚明 2018-05-29 发表::<br>我刚发一篇.说实话.这个期刊要求真心不高</span><span class="quote">加州理工的工人 2018-05-29 05:21:00 发表:<br>我刚发一篇.说实话.这个期刊要求真心不高</span>, beContent=控球后卫-姚明 2018-05-29 发表:: 我刚发一篇.说实话.这个期刊要求真心不高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=743, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd1b2506977, createdName=124af5d5m75暂无昵称, createdTime=Wed Dec 19 00:00:00 CST 2018, time=2018-12-19, status=1, ipAttribution=)]
    2023-04-06 ms5000001244389384 来自上海

    偏重的研究方向：肿瘤
    经验分享：请问目前cell report投稿需要提交所有的原始数据吗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2129298, encodeId=b2fe21292989b, content=好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Sat Apr 29 21:47:11 CST 2023, time=2023-04-29, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124144, encodeId=31c62124144b4, content=偏重的研究方向：肿瘤<br>经验分享：请问cell report 需要提供所有的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb538107486, createdName=ms5000001244389384, createdTime=Thu Apr 06 16:50:15 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124142, encodeId=6be1212414218, content=偏重的研究方向：肿瘤<br>经验分享：请问目前cell report投稿需要提交所有的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb538107486, createdName=ms5000001244389384, createdTime=Thu Apr 06 16:43:11 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1063947, encodeId=90b2106394e9f, content=偏重的研究方向：医学;综合;生物学<br>经验分享：请问和sicnece signaling比哪个难度大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bcd2757433, createdName=826449277, createdTime=Tue Oct 26 06:34:58 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118532, encodeId=4857211853246, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：好杂志，推荐，刚刚中了，作为一个研究生，是不是还不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de436514664, createdName=ms5000001366657176, createdTime=Thu Mar 09 19:15:29 CST 2023, time=2023-03-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223966, encodeId=142e12239666a, content=请教各位前辈，现在这个杂志发表前要求提供PCR原始数据嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5e4748995, createdName=SCI 99, createdTime=Thu Jun 02 01:00:07 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545925, encodeId=158454592530, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：个人感觉目前难度不是很大，相比eLife, PNAS有点差距，不过文章整体质量还是非常好。我的个人经历是投稿到Oncogene结果人家都不审稿，再投到了Cell Rep,小修后接受了，所以投稿的时候还要看是否遇到了欣赏你工作的编辑及审稿人吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08d965864, createdName=xianjuema, createdTime=Sat Aug 26 01:56:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099255, encodeId=ead6209925505, content=一年中无理由的无评语的连续被拒了8次，也不分析为什么被拒，要求重新修改，一直拒绝不可以，说是已经服务了，这算是人性化的服务吗，白白浪费了三万多钱，也浪费时间，一直说服务到位了，中间也没有沟通也不给意见，大家合作时慎重考虑，因为我也没想到会一直被拒，提意见也不接受，我怕大家会出现我的情况，好好参考下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=929c5718991, createdName=ms4000002056955167, createdTime=Tue Nov 08 20:55:43 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232664, encodeId=e8501232664c5, content=求问各位大大送审后修回机率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/28/80e2808f5601a0210ea7aa90667fc272.jpg, createdBy=fe532106727, createdName=yyyanz, createdTime=Fri Jul 15 19:17:20 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564653, encodeId=ccbd56465366, content=是么？<span class="quote">控球后卫-姚明 2018-05-29 发表::<br>我刚发一篇.说实话.这个期刊要求真心不高</span><span class="quote">加州理工的工人 2018-05-29 05:21:00 发表:<br>我刚发一篇.说实话.这个期刊要求真心不高</span>, beContent=控球后卫-姚明 2018-05-29 发表:: 我刚发一篇.说实话.这个期刊要求真心不高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=743, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd1b2506977, createdName=124af5d5m75暂无昵称, createdTime=Wed Dec 19 00:00:00 CST 2018, time=2018-12-19, status=1, ipAttribution=)]
    2021-10-26 826449277

    偏重的研究方向：医学;综合;生物学
    经验分享：请问和sicnece signaling比哪个难度大

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2129298, encodeId=b2fe21292989b, content=好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Sat Apr 29 21:47:11 CST 2023, time=2023-04-29, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124144, encodeId=31c62124144b4, content=偏重的研究方向：肿瘤<br>经验分享：请问cell report 需要提供所有的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb538107486, createdName=ms5000001244389384, createdTime=Thu Apr 06 16:50:15 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124142, encodeId=6be1212414218, content=偏重的研究方向：肿瘤<br>经验分享：请问目前cell report投稿需要提交所有的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb538107486, createdName=ms5000001244389384, createdTime=Thu Apr 06 16:43:11 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1063947, encodeId=90b2106394e9f, content=偏重的研究方向：医学;综合;生物学<br>经验分享：请问和sicnece signaling比哪个难度大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bcd2757433, createdName=826449277, createdTime=Tue Oct 26 06:34:58 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118532, encodeId=4857211853246, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：好杂志，推荐，刚刚中了，作为一个研究生，是不是还不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de436514664, createdName=ms5000001366657176, createdTime=Thu Mar 09 19:15:29 CST 2023, time=2023-03-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223966, encodeId=142e12239666a, content=请教各位前辈，现在这个杂志发表前要求提供PCR原始数据嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5e4748995, createdName=SCI 99, createdTime=Thu Jun 02 01:00:07 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545925, encodeId=158454592530, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：个人感觉目前难度不是很大，相比eLife, PNAS有点差距，不过文章整体质量还是非常好。我的个人经历是投稿到Oncogene结果人家都不审稿，再投到了Cell Rep,小修后接受了，所以投稿的时候还要看是否遇到了欣赏你工作的编辑及审稿人吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08d965864, createdName=xianjuema, createdTime=Sat Aug 26 01:56:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099255, encodeId=ead6209925505, content=一年中无理由的无评语的连续被拒了8次，也不分析为什么被拒，要求重新修改，一直拒绝不可以，说是已经服务了，这算是人性化的服务吗，白白浪费了三万多钱，也浪费时间，一直说服务到位了，中间也没有沟通也不给意见，大家合作时慎重考虑，因为我也没想到会一直被拒，提意见也不接受，我怕大家会出现我的情况，好好参考下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=929c5718991, createdName=ms4000002056955167, createdTime=Tue Nov 08 20:55:43 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232664, encodeId=e8501232664c5, content=求问各位大大送审后修回机率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/28/80e2808f5601a0210ea7aa90667fc272.jpg, createdBy=fe532106727, createdName=yyyanz, createdTime=Fri Jul 15 19:17:20 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564653, encodeId=ccbd56465366, content=是么？<span class="quote">控球后卫-姚明 2018-05-29 发表::<br>我刚发一篇.说实话.这个期刊要求真心不高</span><span class="quote">加州理工的工人 2018-05-29 05:21:00 发表:<br>我刚发一篇.说实话.这个期刊要求真心不高</span>, beContent=控球后卫-姚明 2018-05-29 发表:: 我刚发一篇.说实话.这个期刊要求真心不高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=743, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd1b2506977, createdName=124af5d5m75暂无昵称, createdTime=Wed Dec 19 00:00:00 CST 2018, time=2018-12-19, status=1, ipAttribution=)]
    2023-03-09 ms5000001366657176 来自江苏省

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：好杂志，推荐，刚刚中了，作为一个研究生，是不是还不错

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2129298, encodeId=b2fe21292989b, content=好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Sat Apr 29 21:47:11 CST 2023, time=2023-04-29, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124144, encodeId=31c62124144b4, content=偏重的研究方向：肿瘤<br>经验分享：请问cell report 需要提供所有的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb538107486, createdName=ms5000001244389384, createdTime=Thu Apr 06 16:50:15 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124142, encodeId=6be1212414218, content=偏重的研究方向：肿瘤<br>经验分享：请问目前cell report投稿需要提交所有的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb538107486, createdName=ms5000001244389384, createdTime=Thu Apr 06 16:43:11 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1063947, encodeId=90b2106394e9f, content=偏重的研究方向：医学;综合;生物学<br>经验分享：请问和sicnece signaling比哪个难度大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bcd2757433, createdName=826449277, createdTime=Tue Oct 26 06:34:58 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118532, encodeId=4857211853246, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：好杂志，推荐，刚刚中了，作为一个研究生，是不是还不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de436514664, createdName=ms5000001366657176, createdTime=Thu Mar 09 19:15:29 CST 2023, time=2023-03-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223966, encodeId=142e12239666a, content=请教各位前辈，现在这个杂志发表前要求提供PCR原始数据嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5e4748995, createdName=SCI 99, createdTime=Thu Jun 02 01:00:07 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545925, encodeId=158454592530, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：个人感觉目前难度不是很大，相比eLife, PNAS有点差距，不过文章整体质量还是非常好。我的个人经历是投稿到Oncogene结果人家都不审稿，再投到了Cell Rep,小修后接受了，所以投稿的时候还要看是否遇到了欣赏你工作的编辑及审稿人吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08d965864, createdName=xianjuema, createdTime=Sat Aug 26 01:56:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099255, encodeId=ead6209925505, content=一年中无理由的无评语的连续被拒了8次，也不分析为什么被拒，要求重新修改，一直拒绝不可以，说是已经服务了，这算是人性化的服务吗，白白浪费了三万多钱，也浪费时间，一直说服务到位了，中间也没有沟通也不给意见，大家合作时慎重考虑，因为我也没想到会一直被拒，提意见也不接受，我怕大家会出现我的情况，好好参考下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=929c5718991, createdName=ms4000002056955167, createdTime=Tue Nov 08 20:55:43 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232664, encodeId=e8501232664c5, content=求问各位大大送审后修回机率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/28/80e2808f5601a0210ea7aa90667fc272.jpg, createdBy=fe532106727, createdName=yyyanz, createdTime=Fri Jul 15 19:17:20 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564653, encodeId=ccbd56465366, content=是么？<span class="quote">控球后卫-姚明 2018-05-29 发表::<br>我刚发一篇.说实话.这个期刊要求真心不高</span><span class="quote">加州理工的工人 2018-05-29 05:21:00 发表:<br>我刚发一篇.说实话.这个期刊要求真心不高</span>, beContent=控球后卫-姚明 2018-05-29 发表:: 我刚发一篇.说实话.这个期刊要求真心不高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=743, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd1b2506977, createdName=124af5d5m75暂无昵称, createdTime=Wed Dec 19 00:00:00 CST 2018, time=2018-12-19, status=1, ipAttribution=)]
    2022-06-02 SCI 99

    请教各位前辈，现在这个杂志发表前要求提供PCR原始数据嘛？

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2129298, encodeId=b2fe21292989b, content=好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Sat Apr 29 21:47:11 CST 2023, time=2023-04-29, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124144, encodeId=31c62124144b4, content=偏重的研究方向：肿瘤<br>经验分享：请问cell report 需要提供所有的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb538107486, createdName=ms5000001244389384, createdTime=Thu Apr 06 16:50:15 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124142, encodeId=6be1212414218, content=偏重的研究方向：肿瘤<br>经验分享：请问目前cell report投稿需要提交所有的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb538107486, createdName=ms5000001244389384, createdTime=Thu Apr 06 16:43:11 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1063947, encodeId=90b2106394e9f, content=偏重的研究方向：医学;综合;生物学<br>经验分享：请问和sicnece signaling比哪个难度大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bcd2757433, createdName=826449277, createdTime=Tue Oct 26 06:34:58 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118532, encodeId=4857211853246, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：好杂志，推荐，刚刚中了，作为一个研究生，是不是还不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de436514664, createdName=ms5000001366657176, createdTime=Thu Mar 09 19:15:29 CST 2023, time=2023-03-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223966, encodeId=142e12239666a, content=请教各位前辈，现在这个杂志发表前要求提供PCR原始数据嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5e4748995, createdName=SCI 99, createdTime=Thu Jun 02 01:00:07 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545925, encodeId=158454592530, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：个人感觉目前难度不是很大，相比eLife, PNAS有点差距，不过文章整体质量还是非常好。我的个人经历是投稿到Oncogene结果人家都不审稿，再投到了Cell Rep,小修后接受了，所以投稿的时候还要看是否遇到了欣赏你工作的编辑及审稿人吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08d965864, createdName=xianjuema, createdTime=Sat Aug 26 01:56:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099255, encodeId=ead6209925505, content=一年中无理由的无评语的连续被拒了8次，也不分析为什么被拒，要求重新修改，一直拒绝不可以，说是已经服务了，这算是人性化的服务吗，白白浪费了三万多钱，也浪费时间，一直说服务到位了，中间也没有沟通也不给意见，大家合作时慎重考虑，因为我也没想到会一直被拒，提意见也不接受，我怕大家会出现我的情况，好好参考下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=929c5718991, createdName=ms4000002056955167, createdTime=Tue Nov 08 20:55:43 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232664, encodeId=e8501232664c5, content=求问各位大大送审后修回机率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/28/80e2808f5601a0210ea7aa90667fc272.jpg, createdBy=fe532106727, createdName=yyyanz, createdTime=Fri Jul 15 19:17:20 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564653, encodeId=ccbd56465366, content=是么？<span class="quote">控球后卫-姚明 2018-05-29 发表::<br>我刚发一篇.说实话.这个期刊要求真心不高</span><span class="quote">加州理工的工人 2018-05-29 05:21:00 发表:<br>我刚发一篇.说实话.这个期刊要求真心不高</span>, beContent=控球后卫-姚明 2018-05-29 发表:: 我刚发一篇.说实话.这个期刊要求真心不高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=743, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd1b2506977, createdName=124af5d5m75暂无昵称, createdTime=Wed Dec 19 00:00:00 CST 2018, time=2018-12-19, status=1, ipAttribution=)]
    2017-08-26 xianjuema

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：个人感觉目前难度不是很大，相比eLife, PNAS有点差距，不过文章整体质量还是非常好。我的个人经历是投稿到Oncogene结果人家都不审稿，再投到了Cell Rep,小修后接受了，所以投稿的时候还要看是否遇到了欣赏你工作的编辑及审稿人吧。

    6

    展开6条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2129298, encodeId=b2fe21292989b, content=好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Sat Apr 29 21:47:11 CST 2023, time=2023-04-29, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124144, encodeId=31c62124144b4, content=偏重的研究方向：肿瘤<br>经验分享：请问cell report 需要提供所有的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb538107486, createdName=ms5000001244389384, createdTime=Thu Apr 06 16:50:15 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124142, encodeId=6be1212414218, content=偏重的研究方向：肿瘤<br>经验分享：请问目前cell report投稿需要提交所有的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb538107486, createdName=ms5000001244389384, createdTime=Thu Apr 06 16:43:11 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1063947, encodeId=90b2106394e9f, content=偏重的研究方向：医学;综合;生物学<br>经验分享：请问和sicnece signaling比哪个难度大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bcd2757433, createdName=826449277, createdTime=Tue Oct 26 06:34:58 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118532, encodeId=4857211853246, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：好杂志，推荐，刚刚中了，作为一个研究生，是不是还不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de436514664, createdName=ms5000001366657176, createdTime=Thu Mar 09 19:15:29 CST 2023, time=2023-03-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223966, encodeId=142e12239666a, content=请教各位前辈，现在这个杂志发表前要求提供PCR原始数据嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5e4748995, createdName=SCI 99, createdTime=Thu Jun 02 01:00:07 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545925, encodeId=158454592530, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：个人感觉目前难度不是很大，相比eLife, PNAS有点差距，不过文章整体质量还是非常好。我的个人经历是投稿到Oncogene结果人家都不审稿，再投到了Cell Rep,小修后接受了，所以投稿的时候还要看是否遇到了欣赏你工作的编辑及审稿人吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08d965864, createdName=xianjuema, createdTime=Sat Aug 26 01:56:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099255, encodeId=ead6209925505, content=一年中无理由的无评语的连续被拒了8次，也不分析为什么被拒，要求重新修改，一直拒绝不可以，说是已经服务了，这算是人性化的服务吗，白白浪费了三万多钱，也浪费时间，一直说服务到位了，中间也没有沟通也不给意见，大家合作时慎重考虑，因为我也没想到会一直被拒，提意见也不接受，我怕大家会出现我的情况，好好参考下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=929c5718991, createdName=ms4000002056955167, createdTime=Tue Nov 08 20:55:43 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232664, encodeId=e8501232664c5, content=求问各位大大送审后修回机率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/28/80e2808f5601a0210ea7aa90667fc272.jpg, createdBy=fe532106727, createdName=yyyanz, createdTime=Fri Jul 15 19:17:20 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564653, encodeId=ccbd56465366, content=是么？<span class="quote">控球后卫-姚明 2018-05-29 发表::<br>我刚发一篇.说实话.这个期刊要求真心不高</span><span class="quote">加州理工的工人 2018-05-29 05:21:00 发表:<br>我刚发一篇.说实话.这个期刊要求真心不高</span>, beContent=控球后卫-姚明 2018-05-29 发表:: 我刚发一篇.说实话.这个期刊要求真心不高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=743, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd1b2506977, createdName=124af5d5m75暂无昵称, createdTime=Wed Dec 19 00:00:00 CST 2018, time=2018-12-19, status=1, ipAttribution=)]
    2022-11-08 ms4000002056955167

    一年中无理由的无评语的连续被拒了8次，也不分析为什么被拒，要求重新修改，一直拒绝不可以，说是已经服务了，这算是人性化的服务吗，白白浪费了三万多钱，也浪费时间，一直说服务到位了，中间也没有沟通也不给意见，大家合作时慎重考虑，因为我也没想到会一直被拒，提意见也不接受，我怕大家会出现我的情况，好好参考下

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2129298, encodeId=b2fe21292989b, content=好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Sat Apr 29 21:47:11 CST 2023, time=2023-04-29, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124144, encodeId=31c62124144b4, content=偏重的研究方向：肿瘤<br>经验分享：请问cell report 需要提供所有的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb538107486, createdName=ms5000001244389384, createdTime=Thu Apr 06 16:50:15 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124142, encodeId=6be1212414218, content=偏重的研究方向：肿瘤<br>经验分享：请问目前cell report投稿需要提交所有的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb538107486, createdName=ms5000001244389384, createdTime=Thu Apr 06 16:43:11 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1063947, encodeId=90b2106394e9f, content=偏重的研究方向：医学;综合;生物学<br>经验分享：请问和sicnece signaling比哪个难度大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bcd2757433, createdName=826449277, createdTime=Tue Oct 26 06:34:58 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118532, encodeId=4857211853246, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：好杂志，推荐，刚刚中了，作为一个研究生，是不是还不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de436514664, createdName=ms5000001366657176, createdTime=Thu Mar 09 19:15:29 CST 2023, time=2023-03-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223966, encodeId=142e12239666a, content=请教各位前辈，现在这个杂志发表前要求提供PCR原始数据嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5e4748995, createdName=SCI 99, createdTime=Thu Jun 02 01:00:07 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545925, encodeId=158454592530, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：个人感觉目前难度不是很大，相比eLife, PNAS有点差距，不过文章整体质量还是非常好。我的个人经历是投稿到Oncogene结果人家都不审稿，再投到了Cell Rep,小修后接受了，所以投稿的时候还要看是否遇到了欣赏你工作的编辑及审稿人吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08d965864, createdName=xianjuema, createdTime=Sat Aug 26 01:56:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099255, encodeId=ead6209925505, content=一年中无理由的无评语的连续被拒了8次，也不分析为什么被拒，要求重新修改，一直拒绝不可以，说是已经服务了，这算是人性化的服务吗，白白浪费了三万多钱，也浪费时间，一直说服务到位了，中间也没有沟通也不给意见，大家合作时慎重考虑，因为我也没想到会一直被拒，提意见也不接受，我怕大家会出现我的情况，好好参考下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=929c5718991, createdName=ms4000002056955167, createdTime=Tue Nov 08 20:55:43 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232664, encodeId=e8501232664c5, content=求问各位大大送审后修回机率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/28/80e2808f5601a0210ea7aa90667fc272.jpg, createdBy=fe532106727, createdName=yyyanz, createdTime=Fri Jul 15 19:17:20 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564653, encodeId=ccbd56465366, content=是么？<span class="quote">控球后卫-姚明 2018-05-29 发表::<br>我刚发一篇.说实话.这个期刊要求真心不高</span><span class="quote">加州理工的工人 2018-05-29 05:21:00 发表:<br>我刚发一篇.说实话.这个期刊要求真心不高</span>, beContent=控球后卫-姚明 2018-05-29 发表:: 我刚发一篇.说实话.这个期刊要求真心不高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=743, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd1b2506977, createdName=124af5d5m75暂无昵称, createdTime=Wed Dec 19 00:00:00 CST 2018, time=2018-12-19, status=1, ipAttribution=)]
    2022-07-15 yyyanz

    求问各位大大送审后修回机率大吗？

    5

    展开5条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2129298, encodeId=b2fe21292989b, content=好, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bf26472850, createdName=ms2000000147841561, createdTime=Sat Apr 29 21:47:11 CST 2023, time=2023-04-29, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2124144, encodeId=31c62124144b4, content=偏重的研究方向：肿瘤<br>经验分享：请问cell report 需要提供所有的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb538107486, createdName=ms5000001244389384, createdTime=Thu Apr 06 16:50:15 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2124142, encodeId=6be1212414218, content=偏重的研究方向：肿瘤<br>经验分享：请问目前cell report投稿需要提交所有的原始数据吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fb538107486, createdName=ms5000001244389384, createdTime=Thu Apr 06 16:43:11 CST 2023, time=2023-04-06, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=1063947, encodeId=90b2106394e9f, content=偏重的研究方向：医学;综合;生物学<br>经验分享：请问和sicnece signaling比哪个难度大, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=229, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bcd2757433, createdName=826449277, createdTime=Tue Oct 26 06:34:58 CST 2021, time=2021-10-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2118532, encodeId=4857211853246, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：好杂志，推荐，刚刚中了，作为一个研究生，是不是还不错, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de436514664, createdName=ms5000001366657176, createdTime=Thu Mar 09 19:15:29 CST 2023, time=2023-03-09, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=1223966, encodeId=142e12239666a, content=请教各位前辈，现在这个杂志发表前要求提供PCR原始数据嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5e4748995, createdName=SCI 99, createdTime=Thu Jun 02 01:00:07 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=545925, encodeId=158454592530, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：个人感觉目前难度不是很大，相比eLife, PNAS有点差距，不过文章整体质量还是非常好。我的个人经历是投稿到Oncogene结果人家都不审稿，再投到了Cell Rep,小修后接受了，所以投稿的时候还要看是否遇到了欣赏你工作的编辑及审稿人吧。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=361, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=08d965864, createdName=xianjuema, createdTime=Sat Aug 26 01:56:00 CST 2017, time=2017-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2099255, encodeId=ead6209925505, content=一年中无理由的无评语的连续被拒了8次，也不分析为什么被拒，要求重新修改，一直拒绝不可以，说是已经服务了，这算是人性化的服务吗，白白浪费了三万多钱，也浪费时间，一直说服务到位了，中间也没有沟通也不给意见，大家合作时慎重考虑，因为我也没想到会一直被拒，提意见也不接受，我怕大家会出现我的情况，好好参考下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=929c5718991, createdName=ms4000002056955167, createdTime=Tue Nov 08 20:55:43 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1232664, encodeId=e8501232664c5, content=求问各位大大送审后修回机率大吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/04/28/80e2808f5601a0210ea7aa90667fc272.jpg, createdBy=fe532106727, createdName=yyyanz, createdTime=Fri Jul 15 19:17:20 CST 2022, time=2022-07-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564653, encodeId=ccbd56465366, content=是么？<span class="quote">控球后卫-姚明 2018-05-29 发表::<br>我刚发一篇.说实话.这个期刊要求真心不高</span><span class="quote">加州理工的工人 2018-05-29 05:21:00 发表:<br>我刚发一篇.说实话.这个期刊要求真心不高</span>, beContent=控球后卫-姚明 2018-05-29 发表:: 我刚发一篇.说实话.这个期刊要求真心不高, objectType=tool_impact_factor, channel=null, level=null, likeNumber=743, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd1b2506977, createdName=124af5d5m75暂无昵称, createdTime=Wed Dec 19 00:00:00 CST 2018, time=2018-12-19, status=1, ipAttribution=)]
    2018-12-19 124af5d5m75暂无昵称

    是么？控球后卫-姚明 2018-05-29 发表::
    我刚发一篇.说实话.这个期刊要求真心不高    加州理工的工人 2018-05-29 05:21:00 发表:
    我刚发一篇.说实话.这个期刊要求真心不高

    控球后卫-姚明 2018-05-29 发表:: 我刚发一篇.说实话.这个期刊要求真心不高

    1

    展开1条回复
共354条页码: 2/36页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分